Securities code: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) securities abbreviation: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) Announcement No.: 2022007 Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)
Announcement on online roadshow of public issuance of convertible corporate bonds
Sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918)
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) (hereinafter referred to as ” Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) ” or “the issuer”) has obtained the approval of China Securities Regulatory Commission for the public issuance of 276 million yuan of convertible corporate bonds (hereinafter referred to as “Panlong convertible bonds”).
The convertible bonds issued this time shall be placed preferentially to the original shareholders registered by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch after the closing of the market on the equity registration date. The balance after the priority placement (including the part abandoned by the original shareholders) shall be issued to the public investors through the trading system of Shenzhen Stock Exchange. The full text of the prospectus for convertible corporate bonds issued to the public and relevant information can be found on cninfo.com（ http://www.cn.info.com.cn. ）Query.
In order to facilitate investors to understand the relevant situation of Panlong convertible bonds and the relevant arrangements of this issuance, the issuer and the sponsor (lead underwriter) will hold an online roadshow on this issuance. The following is the relevant information of this roadshow: I. online roadshow time: 15:00-17:00 on Wednesday, March 2, 2022
2、 Online roadshow website: Panoramic roadshow world（ https://rs.p5w.net. ）
3、 Participants: key members of the issuer’s management and relevant personnel of the lead underwriter
Please pay attention to it.
Issuer: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) sponsor (lead underwriter): Zhongtai Securities Co.Ltd(600918) March 1, 2022
